Abstract:BackgroundAmide proton transfer (APT) imaging is a chemical exchange saturation transfer (CEST) technique offering potential clinical applications such as diagnosis, characterization, and treatment planning and monitoring in glioma patients. While APT‐CEST has demonstrated high potential, reproducibility remains underexplored.PurposeTo investigate whether cerebral APT‐CEST with clinically feasible scan time is reproducible in healthy tissue and glioma for clinical use at 3 T.Study TypeProspective, longitudinal.SubjectsTwenty‐one healthy volunteers (11 females; mean age ± SD: 39 ± 11 years) and 6 glioma patients (3 females; 50 ± 17 years: 4 glioblastomas, 1 oligodendroglioma, 1 radiologically suspected low‐grade glioma).Field Strength/Sequence3 T, Turbo Spin Echo ‐ ampling perfection with application optimized contrasts using different flip angle evolution ‐ chemical exchange saturation transfer (TSE SPACE‐CEST).AssessmentAPT‐CEST measurement reproducibility was assessed within‐session (glioma patients, scan session 1; healthy volunteers scan sessions 1, 2, and 3), between‐sessions (healthy volunteers scan sessions 1 and 2), and between‐days (healthy volunteers, scan sessions 1 and 3). The mean APTCEST values and standard deviation of the within‐subject difference (SDdiff) were calculated in whole tumor enclosed by regions of interest (ROIs) in patients, and eight ROIs in healthy volunteers—whole‐brain, cortical gray matter, putamen, thalami, orbitofrontal gyri, occipital lobes, central brain—and compared.Statistical TestsBrown‐Forsythe tests and variance component analysis (VCA) were used to assess the reproducibility of ROIs for the three time intervals. Significance was set at P < 0.003 after Bonferroni correction.ResultsIntratumoral mean APTCEST was significantly higher than APTCEST in healthy‐appearing tissue in patients (0.5 ± 0.46%). The average within‐session, between‐sessions, and between‐days SDdiff of healthy control brains was 0.2% and did not differ significantly with each other (0.76 > P > 0.22). The within‐session SDdiff of whole‐brain was 0.2% in both healthy volunteers and patients, and 0.21% in the segmented tumor. VCA showed that within‐session factors were the most important (60%) for scanning variance.Data ConclusionCerebral APT‐CEST imaging may show good scan–rescan reproducibility in healthy tissue and tumors with clinically feasible scan times at 3 T. Short‐term measurement effects may be the dominant components for reproducibility.Level of Evidence2Technical EfficacyStage 2

Pathological tissue changes in brain tumors affect the pH‐sensitivity of the T1‐corrected apparent exchange dependent relaxation (AREX) of the amide protons

Zero-degree cross sections for the 7Li(p,n)7Be(g.s.+0.43-MeV) reaction in the energy range 80-795 MeV.

Quantitative Assessment of the Effects of Water Proton Concentration and Water T-1 Changes on Amide Proton Transfer (apt) and Nuclear Overhauser Enhancement (noe) Mri: the Origin of the Apt Imaging Signal in Brain Tumor

pH Mapping of Gliomas Using Quantitative Chemical Exchange Saturation Transfer MRI: Quasi‐Steady‐State, Spillover‐, and MT‐Corrected Omega Plot Analysis

Amid proton transfer (APT) and magnetization transfer (MT) MRI contrasts provide complimentary assessment of brain tumors similarly to proton magnetic resonance spectroscopy imaging (MRSI)

Insight into the Quantitative Metrics of Chemical Exchange Saturation Transfer (CEST) Imaging

Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: Application to a rat glioma model at 4.7 tesla.

Influences of Experimental Parameters on Chemical Exchange Saturation Transfer (CEST) Metrics of Brain Tumors Using Animal Models at 4.7T

Reproducibility of 3 T APT‐CEST in Healthy Volunteers and Patients with Brain Glioma

Ph‐sensitive Amide Proton Transfer Effect Dominates the Magnetization Transfer Asymmetry Contrast During Acute Ischemia—quantification of Multipool Contribution to in Vivo CEST MRI

Improving the Detection Sensitivity of Ph‐weighted Amide Proton Transfer MRI in Acute Stroke Patients Using Extrapolated Semisolid Magnetization Transfer Reference Signals

Quasi‐steady‐state (QUASS) reconstruction enhances T1 normalization in apparent exchange‐dependent relaxation (AREX) analysis: A reevaluation of T1 correction in quantitative CEST MRI of rodent brain tumor models

Direct Radiofrequency Saturation Corrected Amide Proton Transfer Tumor MRI at 3T

Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients

Reproducibility of 3D pH‐weighted chemical exchange saturation transfer contrast in the healthy cervical spinal cord

Relationship between multi-pool model-based chemical exchange saturation transfer imaging, intravoxel incoherent motion MRI, and 11C-methionine uptake on PET/CT in patients with gliomas

Inverse Z-spectrum analysis for MT- and spillover-corrected and T1-compensated steady-state pulsed CEST-MRI - application to pH-weighted MRI of acute stroke

Quantitative Assessment of Amide Proton Transfer (apt) and Nuclear Overhauser Enhancement (noe) Imaging with Extrapolated Semisolid Magnetization Transfer Reference (emr) Signals: Ii. Comparison of Three Emr Models and Application to Human Brain Glioma at 3 Tesla

Study of 1H-Magnetic Resonance Spectroscopy in the Peritumoral Edema of Astrocytomas in Brain

Noninvasive Delineation of Glioma Infiltration with Combined 7T Chemical Exchange Saturation Transfer Imaging and MR Spectroscopy: A Diagnostic Accuracy Study

Quantitative Amide Proton Transfer Imaging with Reduced Interferences from Magnetization Transfer Asymmetry for Human Brain Tumors at 3T